1. Epoxyeicosatrienoic acids (EETs) regulate epithelial sodium channel activity by extracellular signal-regulated kinase 1/2 (ERK1/2)-mediated phosphorylation. Pidkovka N, Rao R, Mei S, Gong Y, Harris RC, Wang WH, Capdevila JH (2013) J Biol Chem 288(7): 5223-31
    › Primary publication · 23283969 (PubMed) · PMC3576126 (PubMed Central)
  2. Epithelial-specific deletion of 11β-HSD2 hinders Apcmin/+ mouse tumorigenesis. Jiang L, Yang S, Yin H, Fan X, Wang S, Yao B, Pozzi A, Chen X, Harris RC, Zhang MZ (2013) Mol Cancer Res 11(9): 1040-50
    › Primary publication · 23741059 (PubMed) · PMC3778073 (PubMed Central)
  3. Diabetic nephropathy: a national dialogue. Breyer MD, Coffman TM, Flessner MF, Fried LF, Harris RC, Ketchum CJ, Kretzler M, Nelson RG, Sedor JR, Susztak K, Kidney Research National Dialogue (KRND) (2013) Clin J Am Soc Nephrol 8(9): 1603-5
    › Primary publication · 23788618 (PubMed) · PMC3805071 (PubMed Central)
  4. Specific deletion of glycogen synthase kinase-3β in the renal proximal tubule protects against acute nephrotoxic injury in mice. Howard C, Tao S, Yang HC, Fogo AB, Woodgett JR, Harris RC, Rao R (2012) Kidney Int 82(9): 1000-9
    › Primary publication · 22785175 (PubMed) · PMC3472082 (PubMed Central)
  5. SOD1, but not SOD3, deficiency accelerates diabetic renal injury in C57BL/6-Ins2(Akita) diabetic mice. Fujita H, Fujishima H, Takahashi K, Sato T, Shimizu T, Morii T, Shimizu T, Shirasawa T, Qi Z, Breyer MD, Harris RC, Yamada Y, Takahashi T (2012) Metabolism 61(12): 1714-24
    › Primary publication · 22632894 (PubMed) · PMC4360989 (PubMed Central)
  6. Role of blood pressure and the renin-angiotensin system in development of diabetic nephropathy (DN) in eNOS-/- db/db mice. Zhang MZ, Wang S, Yang S, Yang H, Fan X, Takahashi T, Harris RC (2012) Am J Physiol Renal Physiol 302(4): F433-8
    › Primary publication · 22114203 (PubMed) · PMC3289417 (PubMed Central)
  7. Podocyte ACE2 protects against diabetic nephropathy. Harris RC (2012) Kidney Int 82(3): 255-6
    › Primary publication · 22791320 (PubMed) · PMC7112297 (PubMed Central)
  8. New isoform-specific monoclonal antibodies reveal different sub-cellular localisations for talin1 and talin2. Praekelt U, Kopp PM, Rehm K, Linder S, Bate N, Patel B, Debrand E, Manso AM, Ross RS, Conti F, Zhang MZ, Harris RC, Zent R, Critchley DR, Monkley SJ (2012) Eur J Cell Biol 91(3): 180-91
    › Primary publication · 22306379 (PubMed) · PMC3629562 (PubMed Central)
  9. Intrarenal dopamine modulates progressive angiotensin II-mediated renal injury. Yang S, Yao B, Zhou Y, Yin H, Zhang MZ, Harris RC (2012) Am J Physiol Renal Physiol 302(6): F742-9
    › Primary publication · 22169008 (PubMed) · PMC3311314 (PubMed Central)
  10. Intrarenal dopamine inhibits progression of diabetic nephropathy. Zhang MZ, Yao B, Yang S, Yang H, Wang S, Fan X, Yin H, Fogo AB, Moeckel GW, Harris RC (2012) Diabetes 61(10): 2575-84
    › Primary publication · 22688335 (PubMed) · PMC3447896 (PubMed Central)